Alpine Global Management’s Gilead Sciences GILD Stock Holding History

Alpine Global Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,455	Closed	-$253K	–	490
2024 Q1	$253K	Buy	3,455 +261	+8%	+$20.1K	0.05%	153
2023 Q4	$259K	Buy	+3,194	New	+$249K	0.07%	125
2020 Q3	–	Sell	-12,523	Closed	-$964K	–	322
2020 Q2	$964K	Buy	+12,523	New	+$960K	0.17%	95
2017 Q4	–	Sell	-9,949	Closed	-$806K	–	219
2017 Q3	$806K	Buy	+9,949	New	+$761K	0.23%	68
2017 Q2	–	Sell	-8,326	Closed	-$566K	–	214
2017 Q1	$566K	Buy	+8,326	New	+$585K	0.15%	119
2015 Q3	–	Sell	-10,336	Closed	-$1.21M	–	382
2015 Q2	$1.21M	Buy	10,336 +2,096	+25%	+$229K	0.2%	87
2015 Q1	$809K	Sell	8,240 -10,540	-56%	-$1.07M	0.26%	82
2014 Q4	$1.77M	Buy	+18,780	New	+$1.94M	0.32%	76

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alpine Global Management's GILD Position: Q2 2024 in Review

Alpine Global Management sold out of Gilead Sciences (GILD) in Q2 2024, closing a stake of 3,455 shares — an estimated $253K sold.

Alpine Global Management first reported a position in GILD in Q4 2014 and held it in 8 quarters. The position peaked at $1.77M in Q4 2014. 1,678 funds tracked by Wall St. Rank hold GILD as of Q2 2024.

Alpine Global Management reported no remaining Gilead Sciences position as of Q2 2024 after selling out during the quarter.
Alpine Global Management sold 3,455 Gilead Sciences shares in Q2 2024, an estimated $253K.
Alpine Global Management first reported a position in Gilead Sciences in Q4 2014 and held it in 8 quarters.
Alpine Global Management's Gilead Sciences position peaked at $1.77M in Q4 2014.
1,678 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2024.

Based on Alpine Global Management's 13F filing for Q2 2024, filed 14 Aug 2024.